Absci, PrecisionLife Partner to Develop AI-Enabled Drug Pipeline
What You Should Know:
– Absci, a generative AI drug creation company, and PrecisionLife, a pioneer in computational biology for complex chronic diseases, have announced a powerful partnership to develop a joint portfolio of potential…
Continue Reading
